COMMUNIQUÉS West-GlobeNewswire

Gain Therapeutics Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for GBA1 Parkinson’s Disease

24/04/2024 - 15:25

BETHESDA, Md., April 24, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of [...]

Spectral AI Names Erich Spangenberg CEO of its IP Focused Subsidiary and Explores Potential Spin-Off of that Subsidiary

24/04/2024 - 15:10

Spangenberg brings significant IP monetization experience and the potential to unlock additional value for Spectral AI shareholders DALLAS, April 24, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral [...]

Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center

24/04/2024 - 15:05

-- Helius Medical and Shepherd Center partner on a study that aims at rehabilitating walking mobility in people recovering from stroke -- -- Shepherd Center, a top neurorehabilitation hospital, is the third site in [...]

Eko2o S.A.S., a Majority-Controlled Subsidiary of MedCana/SFWJ Advances as Leading Infrastructure Supplier for Colombia’s Top Flower Producers

24/04/2024 - 15:00

Collaboration with Danziger International is also enhanced as company’s global footprint expands AUSTIN, Texas, April 24, 2024 (GLOBE NEWSWIRE) -- via IBN – Eko2o S.A.S., a pioneering force in agricultural technology [...]

Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy

24/04/2024 - 15:00

-Company Aligned with FDA on Demonstration of Non-Clinical Comparability; Allowing for Immediate Use of San Diego Manufacturing Facility- -FDA Feedback Supports Requests for a Pre-BLA Meeting and Subsequent Rolling BLA [...]

HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG

24/04/2024 - 15:00

Patent covers use of AI-ECG for any echo measure of diastolic function, which is crucial for heart screening and early detection of heart disease Southlake, Texas, April 24, 2024 (GLOBE NEWSWIRE) -- Heart Test [...]

Sharecare awarded three-year NCQA Accreditation for Case Management

24/04/2024 - 15:00

Accreditation for its complex case management capabilities complements Sharecare's existing three-year NCQA accreditations for Population Health Program and Wellness and Health Promotion ATLANTA, April 24, 2024 (GLOBE [...]

RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership

24/04/2024 - 15:00

LOS ANGELES and AMSTERDAM, April 24, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (Nasdaq: RENB), a trailblazer in AI-driven early cancer diagnostics and therapeutics, and Cyclomics, a leader in ultra-sensitive 4th generation [...]

Verana Health Announces Launch of Qdata® Thyroid Eye Disease

24/04/2024 - 15:00

Expansive real-world dataset, comprising more than 250,000 de-identified patients, will help advance research and expedite therapy development for thyroid eye disease SAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) -- [...]

T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024

24/04/2024 - 15:00

LEXINGTON, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report [...]

Autonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar

24/04/2024 - 15:00

Live webcast on Wednesday, May 1 st at 3:20 PM ET THE WOODLANDS, TX, April 24, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on [...]

Canadians Come Together to Make Positive Impact During Multiple Sclerosis Awareness Month This May

24/04/2024 - 15:00

MS Canada welcomes people across the nation to support the MS community by participating in its signature initiatives as they work toward a world free from MS TORONTO, April 24, 2024 (GLOBE NEWSWIRE) -- May is Multiple [...]

Doheny Eye Institute Announces Upcoming Presentations at ARVO 2024 Annual Meeting

24/04/2024 - 15:00

More than 25 Doheny Scientists Selected to Give Talks and Present Papers and Posters; Director of Artificial Intelligence & Imaging Research SriniVas R. Sadda, MD, to Step Into Role as ARVO President PASADENA, Calif [...]

Novo Nordisk A/S - Articles of Association, April 2024

24/04/2024 - 14:57

Novo Nordisk's Articles of Association, April 2024 Attachment Articles of Association 24 Apr 2024

Novo Nordisk A/S – Reduction of the share capital

24/04/2024 - 14:48

Bagsværd, Denmark, 24 April 2024 – At Novo Nordisk’s Annual General Meeting on 21 March 2024, it was decided to reduce the company’s B share capital from DKK 343,512,800 to DKK 339,012,800 by cancellation of part of the [...]

Altamira Therapeutics Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal

24/04/2024 - 14:47

Hamilton, Bermuda, April 24, 2024 (GLOBE NEWSWIRE) -- Detailed results from randomized controlled Bentrio® trial in seasonal allergic rhinitis published in Allergy journal Study met primary efficacy endpoint of [...]

United Kingdom’s MHRA Approves YORVIPATH® (palopegteriparatide) in Great Britain for the Treatment of Adults with Chronic Hypoparathyroidism

24/04/2024 - 14:30

COPENHAGEN, Denmark, April 24, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the United Kingdom’s Medicines & Healthcare products Regulatory Agency (MHRA) has granted marketing [...]

Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024

24/04/2024 - 14:30

CAMBRIDGE, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that it will report its first- [...]

Smart for Life Appoints Prominent Industry Executive David Trosin to Company’s Advisory Board

24/04/2024 - 14:30

Managing Director of Health Sciences Certification at NSF International Joins Highly Diversified Team of Advisors at Smart for Life MIAMI, April 24, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“Smart [...]